Credit Agricole Downgrades Bio-Rad Labs (BIO) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $364.42 -0.48%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 21 | New: 69
Join SI Premium – FREE
Credit Agricole downgraded Bio-Rad Labs (NYSE: BIO) from Buy to Outperform, price target lowered from $133 to $110.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $91.94 yesterday.
For an analyst ratings summary and ratings history on Bio-Rad Labs click here. For more ratings news on Bio-Rad Labs click here.
Shares of Bio-Rad Labs closed at $91.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Double Downgrades Adobe (ADBE) to Underweight, 'more cautious on front office + creative'
- Deutsche Bank Downgrades C.H. Robinson Worldwide (CHRW) to Hold
- JPMorgan Downgrades Shandong Gold (1787:HK) to Underweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit AgricoleSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
